{
 "ok": true,
 "cik": "1541157",
 "ticker": "AKTX",
 "name": "Akari Therapeutics, Plc",
 "filings": [
  {
   "form": "DEF 14A",
   "filed": "2026-10-01",
   "items": [],
   "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226045371/0001493152-26-045371-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-10-01",
   "items": [
    "5.02 Departure or Election of Directors; Appointment of Officers",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226045364/0001493152-26-045364-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-08-13",
   "items": [
    "2.02 Results of Operations and Financial Condition",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226037736/0001493152-26-037736-index.htm"
  },
  {
   "form": "10-Q",
   "filed": "2026-08-13",
   "items": [],
   "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226037730/0001493152-26-037730-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-07-02",
   "items": [
    "5.07 Submission of Matters to a Vote of Security Holders",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226031972/0001493152-26-031972-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-06-26",
   "items": [
    "1.01 Entry into a Material Definitive Agreement",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226030341/0001493152-26-030341-index.htm"
  }
 ],
 "events12m": 14,
 "healthWatch": {
  "window": "last 12 months",
  "since": "2025-10-02",
  "signals": [
   {
    "code": "3.01",
    "label": "Exchange listing notice or transfer",
    "count": 1,
    "latest": {
     "filed": "2025-11-26",
     "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315225025177/0001493152-25-025177-index.htm"
    }
   },
   {
    "code": "NT 10-Q",
    "label": "Late quarterly report notice",
    "count": 1,
    "latest": {
     "filed": "2026-05-18",
     "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226024230/0001493152-26-024230-index.htm"
    }
   },
   {
    "code": "5.02",
    "label": "Director or officer change",
    "count": 2,
    "latest": {
     "filed": "2026-10-01",
     "url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226045364/0001493152-26-045364-index.htm"
    }
   }
  ],
  "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt."
 },
 "sources": {
  "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001541157.json",
  "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1541157"
 },
 "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.",
 "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.",
 "edgar": "🫧 Edgar looked up Akari Therapeutics, Plc ($AKTX). Last filing: DEF 14A, 2026-10-01. 14 event filings (8-K) in the past twelve months.",
 "auditor": {
  "changes": [],
  "nonReliance": [],
  "restatedSince": null
 },
 "edgarette": "🔖 The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed."
}